000			01579nam a2200445 i 4500
001			ocn951215497
003			BD
005			20161116131235.0
008			160606s2016 dcu l f000 0 eng c
040			_aPUCPR _beng _erda _cGPO
041			_aspa
042			_apcc
043			_an-us---
049			_aBDCG
050			_aKF 50 _b.U56
074			_a0575
086	0		_aAE 2.110:114-145
088			_aPublic Law 114-145
099			_aAE 2.110:114-145
110	1		_aUnited States, _eenacting jurisdiction.
245	1	0	_aEnsuring Patient Access and Effective Drug Enforcement Act of 2016.
246	1	6	_aAct to Improve Enforcement Efforts Related to Prescription Drug Diversion and Abuse, and for Other Purposes
264		1	_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c[2016]
300			_a[3] pages ; _c24 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
500			_aTitle from caption.
500			_aShipping list no.: 2016-0275-P.
500			_a"Apr. 19, 2016 (S. 483)"--P. [1].
500			_a"130 Stat. 354"--P. [1].
500			_a"Public Law 114-145."
500			_aCRDP Project record.
650		0	_aDrugs of abuse _xLaw and legislation _zUnited States.
650		0	_aDrugs _xLaw and legislation _zUnited States.
650		0	_aDrug accessibility _zUnited States.
655		7	_aStatutes and codes. _2lcgft
776	0	8	_iOnline version: _aUnited States. _tEnsuring Patient Access and Effective Drug Enforcement Act of 2016 _w(OCoLC)949907043
942			_2lcc _c15
999			_c253438 _d253438